BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 2:12:02 AM | Browse: 365 | Download: 725
 |
Received |
|
2021-01-31 13:02 |
|
Peer-Review Started |
|
2021-01-31 13:13 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-14 06:00 |
|
Revised |
|
2021-03-25 05:50 |
|
Second Decision |
|
2021-04-02 12:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-02 19:14 |
|
Articles in Press |
|
2021-04-02 19:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-04-12 20:02 |
|
Typeset the Manuscript |
|
2021-04-27 01:39 |
|
Publish the Manuscript Online |
|
2021-04-29 02:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang and Jia-Jie Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhejiang Provincial Natural Science Foundation |
LY18H190002 |
|
| Corresponding Author |
Dan-Hong Yang, PhD, Chief Doctor, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou 310014, Zhejiang Province, China. ydh-11@163.com |
| Key Words |
Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Risk factors; Nucleos(t)ide analogs; Progression |
| Core Tip |
This is a retrospective cross-sectional study to analyze risk factors of Hepatocellular carcinoma (HCC) progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy for at least 6 mo. We discussed the diagnostic value of the serum alpha-fetoprotein level was evaluated in those patients. The results of the present study increase our understanding of HCC pathogenesis and help to provide HCC prevention and control strategies. |
| Publish Date |
2021-04-29 02:12 |
| Citation |
Yang DH, Wang WP, Zhang Q, Pan HY, Huang YC, Zhang JJ. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World J Gastroenterol 2021; 27(17): 2025-2038 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i17/2025.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i17.2025 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
